Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Estuardo Rosales"'
Autor:
Roberta Demichelis, Martha Alvarado, Jule F Vasquez, Nancy Delgado, Cynthia Gómez, Karla Adriana Espinosa, Ana Cooke, Andrea Milan, Andres Gomez-De Leon, Lee-Tsai Yu Ling, Daniel Estuardo Rosales, Alvaro Cabrero Garcia, Lauro Fabian Amador, Carmina Alejandra Córdova-Ramírez, Iván Murrieta-Álvarez, Juan Carlos Solís-Poblano, Elia Ixel Apodaca, Juan Rangel-Patiño, Jose Luis Álvarez, Luara Arana, Jose Antonio De la Peña-Celaya, María Eugenia Espitia, Eleazar Hernandez, Juan Manuel Perez, Rosa González-Rivera, María Fernanda García-Leyva, Estefania Peña, Monica Tejeda Romero, Carolina Balderas-Delgado, Jorge Cruz Rico, Guillermo Ruiz Arguelles, David Gomez-Almaguer
Publikováno v:
Blood
Introduction The COVID-19 pandemic has affected the entire world. Health systems have been affected in such a way that patients with diseases other than COVID-19 have suffered serious consequences. In Latin America, the disease has emerged in a fragi
Autor:
Rixci Ramirez, Marisol Gramajo, Carolina Camey, Jennifer Dominguez, Daniel Estuardo Rosales Lopez
Publikováno v:
Journal of Clinical Oncology. 38:e14500-e14500
e14500 Background: In previous studies separately, it has already been determined how the inflammatory response measured by it neutrophilia and also lymphopenia s with temozolamide have determined that they are important at the time of initiation of
Autor:
Daniel Estuardo Rosales Lopez, Rixci Ramirez, Marisol Gramajo, Carolina Camey, Francisco Javier Godinez
Publikováno v:
Journal of Clinical Oncology. 38:318-318
318 Background: Gastric cancer (GC) in Guatemala is the second most common cancer diagnosis and the second leading cause of cancer death in both sexes. It is difficult to determine the exact incidence rate of H. pylori infection‐negative gastric ca
Autor:
Rixci Ramirez, Gustavo Oliva Vega, Alfredo Mansilla, Francisco Godinez Jerez, Daniel Estuardo Rosales Lopez, Carolina Camey
Publikováno v:
Journal of Clinical Oncology. 37:e16117-e16117
e16117 Background: Lymphopenia is associated with toxicity and clinical outcomes in several types of cancer. Decrease in absolute lymphocyte count (ALC) has been observed in the treatment with sunitinib. Objective: characterize lymphopenia ( < 1000/